Loading company…
Qnomx provides genomic profiling tools to support personalized medicine.
Qnomx develops a genomic profiling platform that interprets genetic data to help healthcare providers tailor treatment. It serves hospitals, research institutions and medical practices. Based in Basel, Switzerland, the company raised EUR 1.7 mn in pre-seed funding in April 2025 for its GenAI platform.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in